These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2459010)

  • 1. Defibrinogenation by batroxobin and acylated batroxobin in rats.
    Richter M; Paintz M; Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):147-51. PubMed ID: 2459010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrinogenation with benzoyl-batroxobin.
    Markwardt F; Paintz M; Richter M; Stürzebecher J
    Thromb Res; 1985 Oct; 40(1):41-7. PubMed ID: 3911486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinolytic activity of acyl-urokinase].
    Stürzebecher J; Kroneck I; Klöcking HP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):137-43. PubMed ID: 2427394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the mechanism of batroxobin-induced fibrinolysis.
    Klöcking HP; Markwardt F; Güttner J
    Pharmazie; 1989 Jul; 44(7):504-5. PubMed ID: 2510188
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of the snake venom batroxobin (Defibrase) on the degree of inflammatory reactions and on fibrinogen and C-reactive protein levels in rats.
    Hirschelmann R; Schade R; Lange U; Bekemeier H
    Pharmazie; 1989 Jul; 44(7):505-6. PubMed ID: 2813493
    [No Abstract]   [Full Text] [Related]  

  • 6. Antimetastatic effect of defibrinogenation with batroxobin depends on the natural killer activity of host in mice.
    Shibuya M; Niitani H; Aoyama A; Kawachi S; Nukariya N; Baba M; Iizuka K; Sakai S; Ohtsuka M
    J Cancer Res Clin Oncol; 1990; 116(2):168-72. PubMed ID: 2324160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental animal research on the thrombolytic effect of acyl-plasmin].
    Nowak G; Stürzebecher J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):144-50. PubMed ID: 2427395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of batroxobin, a serine proteinase from Bothrops snake venom, by derivatives of benzamidine.
    Stürzebecher J; Stürzebecher U; Markwardt F
    Toxicon; 1986; 24(6):585-95. PubMed ID: 3529503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the platelet aggregation induced by three thrombin-like enzymes of snake venoms and thrombin.
    Teng CM; Ko FN
    Thromb Haemost; 1988 Apr; 59(2):304-9. PubMed ID: 3291184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defibrinogenating enzymes.
    Bell WR
    Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated thrombin-activatable fibrinolysis inhibitor attenuates spontaneous fibrinolysis of batroxobin-induced fibrin deposition in rat lungs.
    Wu C; Dong N; da Cunha V; Martin-McNulty B; Tran K; Nagashima M; Wu Q; Morser J; Wang YX
    Thromb Haemost; 2003 Sep; 90(3):414-21. PubMed ID: 12958609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogenolytic proteases isolated from the snake venom of Taiwan habu: serine proteases with kallikrein-like and angiotensin-degrading activities.
    Hung CC; Chiou SH
    Biochem Biophys Res Commun; 2001 Mar; 281(4):1012-8. PubMed ID: 11237764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacologic influence on secondary generalized fibrinolysis].
    Markwardt F; Drawert J; Perlewitz J
    Acta Biol Med Ger; 1979; 38(8):1201-9. PubMed ID: 532498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-thrombotic effect of a PAI-1 inhibitor in rats given endotoxin.
    Abrahamsson T; Nerme V; Strömqvist M; Akerblom B; Legnehed A; Pettersson K; Westin Eriksson A
    Thromb Haemost; 1996 Jan; 75(1):118-26. PubMed ID: 8713790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in mRNA levels of fibrinogen subunit polypeptides in rats defibrinogenated with batroxobin.
    Iwai S; Okazaki M; Kiuchi Y; Oguchi K
    Thromb Res; 1999 Dec; 96(6):421-6. PubMed ID: 10632464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New model for in vivo studies of pharmacological interventions with endogenous fibrinolysis: effects of thrombin inhibitors.
    Lenfors S; Gustafsson D
    Semin Thromb Hemost; 1996; 22(4):335-42. PubMed ID: 8944418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris.
    You WK; Choi WS; Koh YS; Shin HC; Jang Y; Chung KH
    FEBS Lett; 2004 Jul; 571(1-3):67-73. PubMed ID: 15280019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of cell-transferred experimental autoimmune encephalomyelitis in defibrinated Lewis rats.
    Inoue A; Koh CS; Shimada K; Yanagisawa N; Yoshimura K
    J Neuroimmunol; 1996 Dec; 71(1-2):131-7. PubMed ID: 8982112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of endogenous fibrinolysis inhibition in the dog. Effect of intravascular coagulation and release of free fatty acids.
    Lindquist O; Bagge L; Saldeen T
    Acta Chir Scand; 1976; 142(1):20-5. PubMed ID: 1266538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.